Stroke RehabilitationNCT06323330
Music Therapy for Rehabilitation in Post-stroke Non-fluent Aphasia: the Indian Adaptation
A study testing Speech rehabilitation in people with Stroke Rehabilitation and Aphasia, Broca, run by All India Institute of Medical Sciences at 3 sites in India.
Trial summary
The goal of this Interventional Study is to develop and test the Indian Adaptation of Melodic Intonation Therapy (MIT) for Indian patients in with post-stroke Non-Fluent Aphasia (PSNFA). Read more about this study
- Who is it for?
- Ages 18 to 99 years
- Conditions the study is for
- Stroke Rehabilitation, Aphasia, Broca
- What is being tested?
- Speech rehabilitation
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 3 sitesIndia
- Study dates
- 1 Jun 2024to 30 Jan 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- All of the following
- Age ≥18 years of age
- Stroke with non-fluent aphasia, within one year of ictus
- Imaging evidence suggestive of ischemic or hemorrhagic stroke of dominant hemisphere
- Patient is alert and able to follow simple commands (should not have global aphasia)
- Motivated caregiver
- Informed and signed consent
Who cannot join
- Any of the following:
- Patients with a history of a previous stroke other than the index event, which can explain the aphasia.
- Any clinical condition (e.g., short life expectancy, coexisting disease) or other characteristics that preclude appropriate follow-up in the study (e.g., distant residence, no family support)
- Patients participating in any therapeutic intervention clinical trials evaluating poststroke recovery
- Use of psychotropic drugs that interfere with patient evaluation
Trial locations and contacts
3 sites in 1 country. Contact the study team or a site near you to ask about taking part.
India3 sites, 3 recruiting
- Recruiting
Institute of Human Behavior and Allied Sciences
Delhi, National Capital Territory of Delhi, 110029
Deepti Vibha, 09868398263, deeptivibha@gmail.com
- Recruiting
All India Institute of Medical Sciences, New Delhi
New Delhi, National Capital Territory of Delhi, 110029
Deepti Vibha, 09868398263, deeptivibha@gmail.com
- Recruiting
Safdarjung Hospital
New Delhi, National Capital Territory of Delhi, 110029
Deepti Vibha, 09868398263, deeptivibha@gmail.com
About this study
The goal of this Interventional Study is to develop and test the Indian Adaptation of Melodic Intonation Therapy (MIT) for Indian patients in with post-stroke Non-Fluent Aphasia (PSNFA). The main question[s] it aims to answer are: • To develop the MIT Indian Adaptation tool and check its feasibility • To compare the MIT with standard speech rehabilitation in patient with PSNFA. Participants will undergo Speech Rehabilitation according to the developed module and the standard treatment will be given in the comparator arm. The speech recovery at 12 weeks will be compared in both treatment arms.
Read the detailed description
The study will be done in two stages:
- Stage 1 (Intervention formulation): A battery for therapy will be formulated with the help of SLT in conjunction with the expert(s) in Indian music, neurologist, and physiologist. In a series of physical and online meetings, the duration, frequency, and content of the therapy programme will be formulated. The stage(s) at which NIRS will be conducted will also be decided. This will not involve any patient recruitment and should be finished in three months.
- Stage 2 (Feasibility phase): The feasibility run will be done in 10 eligible patients. With further adaptations depending upon the experience in the feasibility phase, the pilot phase will be conducted, in which the treatment arms will be randomized.
- Stage 2 (Pilot phase): Assuming standard error of measurement for participants with aphasia as 4.33 points with a 5-point difference considered clinically meaningful for the Western Aphasia Battery (WAB), and considering that no such prior study is there, 30 patients in intervention and control arm would be initially taken. Therefore, the total sample size 10+30+30=70 patients.
- The randomization will be done in 1:1 ratio, via a computer-generated random number sequence which will be in a sealed opaque envelope. The allocation will be concealed, and the treatment arm will be revealed after the patient has been screened and has consented for the study.
- The outcome assessment will be by a blinded assessor, who will be a co-investigator in the study.
- Conditions
- Stroke Rehabilitation, Aphasia, Broca
- Being tested
- Speech rehabilitation
- Keywords
- Post stroke non-fluent aphasia, Melodic Intonation Therapy, Indian Adaptation
- Medical subject headings
- Aphasia, Broca
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Speech rehabilitationOther
Melodic Intonation Therapy- Indian Adaptation module which will be developed in the pilot phase
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | The intervention arm will be given the Music Therapy, the Indian language adapted module Receives: Other: Speech rehabilitation |
| Active comparator | Active comparator | The active comparator arm will be given the standard speech rehabilitation. Receives: Other: Speech rehabilitation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Western Aphasia Battery Score
Measured: 8 weeks
Secondary outcomes (4)
Western Aphasia Battery Score
Measured: 4 weeks
functional Near Red Spectroscopy measures
Measured: 8 weeks
modified Rankin Score
Measured: 8 weeks
Fugl Meyer Assessment Scores
Measured: 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Mar 2024
- Study start1 Jun 2024
- Primary completion31 Oct 2026 (estimated)
- Study completion30 Jan 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Stroke RehabilitationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The MIT- Indian Adaptation will be tested and compared with standard speech rehabilitation in post-stroke non-fluent aphasia
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- All India Institute of Medical Sciences
- Sponsor type
- University, hospital or other
- Collaborators
- Institute of Human Behavior and Allied Sciences, Indian Institute of Technology, New Delhi, Vardhman Mahavir Medical College And Safdarjung Hospital
- Responsible party
- Principal investigator, Deepti Vibha, All India Institute of Medical Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06323330
- Sponsor's protocol ID
- I-1623
- Status last verified
- Sep 2026
- First submitted
- 15 Mar 2024
- Last updated
- 13 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: IPD will be shared upon request to the PI
Study at a glance
From the registry record, last updated by the sponsor on 13 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Music Therapy for Rehabilitation in Post-stroke Non-fluent Aphasia: the Indian Adaptation
- ClinicalTrials.gov ID
- NCT06323330
- Acronym / sponsor ID
- I-1623
- Conditions
- Stroke Rehabilitation, Aphasia, Broca
- Keywords
- Post stroke non-fluent aphasia, Melodic Intonation Therapy, Indian Adaptation
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- All India Institute of Medical SciencesUniversity, hospital or other
- Collaborators
- Institute of Human Behavior and Allied Sciences, Indian Institute of Technology, New Delhi, Vardhman Mahavir Medical College And Safdarjung Hospital
- Study start
- 1 Jun 2024 (actual)
- Primary completion
- 31 Oct 2026 (estimated)
- Study completion
- 30 Jan 2027 (estimated)
- First posted
- 21 Mar 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this Interventional Study is to develop and test the Indian Adaptation of Melodic Intonation Therapy (MIT) for Indian patients in with post-stroke Non-Fluent Aphasia (PSNFA). The main question[s] it aims to answer are: • To develop the MIT Indian Adaptation tool and check its feasibility • To compare the MIT with standard speech rehabilitation in patient with PSNFA. Participants will undergo Speech Rehabilitation according to the developed module and the standard treatment will be given in the comparator arm. The speech recovery at 12 weeks will be compared in both treatment arms.
Detailed description
The study will be done in two stages:
- Stage 1 (Intervention formulation): A battery for therapy will be formulated with the help of SLT in conjunction with the expert(s) in Indian music, neurologist, and physiologist. In a series of physical and online meetings, the duration, frequency, and content of the therapy programme will be formulated. The stage(s) at which NIRS will be conducted will also be decided. This will not involve any patient recruitment and should be finished in three months.
- Stage 2 (Feasibility phase): The feasibility run will be done in 10 eligible patients. With further adaptations depending upon the experience in the feasibility phase, the pilot phase will be conducted, in which the treatment arms will be randomized.
- Stage 2 (Pilot phase): Assuming standard error of measurement for participants with aphasia as 4.33 points with a 5-point difference considered clinically meaningful for the Western Aphasia Battery (WAB), and considering that no such prior study is there, 30 patients in intervention and control arm would be initially taken. Therefore, the total sample size 10+30+30=70 patients.
- The randomization will be done in 1:1 ratio, via a computer-generated random number sequence which will be in a sealed opaque envelope. The allocation will be concealed, and the treatment arm will be revealed after the patient has been screened and has consented for the study.
- The outcome assessment will be by a blinded assessor, who will be a co-investigator in the study.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- The MIT- Indian Adaptation will be tested and compared with standard speech rehabilitation in post-stroke non-fluent aphasia
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Other: Speech rehabilitationThe intervention arm will be given the Music Therapy, the Indian language adapted module |
| Active comparator | Active comparator | Other: Speech rehabilitationThe active comparator arm will be given the standard speech rehabilitation. |
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- All of the following
- Age ≥18 years of age
- Stroke with non-fluent aphasia, within one year of ictus
- Imaging evidence suggestive of ischemic or hemorrhagic stroke of dominant hemisphere
- Patient is alert and able to follow simple commands (should not have global aphasia)
Key exclusion criteria (5 listed)
- Patients with a history of a previous stroke other than the index event, which can explain the aphasia.
- Any clinical condition (e.g., short life expectancy, coexisting disease) or other characteristics that preclude appropriate follow-up in the study (e.g., distant residence, no family support)
- Patients participating in any therapeutic intervention clinical trials evaluating poststroke recovery
- Use of psychotropic drugs that interfere with patient evaluation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Speech rehabilitationMelodic Intonation Therapy- Indian Adaptation module which will be developed in the pilot phase | Other | Active comparator, Intervention |
Primary outcome
Western Aphasia Battery Score
Time frame: 8 weeks
4 secondary outcomes
Western Aphasia Battery Score
Time frame: 4 weeks
functional Near Red Spectroscopy measures
Time frame: 8 weeks
modified Rankin Score
Time frame: 8 weeks
Fugl Meyer Assessment Scores
Time frame: 8 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Oct 2026.
- Individual participant dataSharing planned: Undecided. IPD will be shared upon request to the PI
Related trials for Stroke Rehabilitation
Recruiting
Web-Based Tele-Rehabilitation Using Action Observation and Mirror Therapy for Subacute Stroke: A Randomized Controlled Trial
Stroke, Upper Extremity Paresis
Recruiting
Biomarkers of Paired VNS
Stroke, Ischemic
Not yet recruiting
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Stroke, Parkinson's Disease (PD)
Recruiting
Cervical tsDCS on Stroke Patients
Functional Recovery, Motor Rehabilitation
Not yet recruiting
Virtual Reality Training Dose for Arm Recovery After Stroke: Clinical and Blood Biomarker Responses
Stroke, Upper Extremity Paresis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Speech rehabilitation in people with Stroke Rehabilitation and Aphasia, Broca, run by All India Institute of Medical Sciences at 3 sites in India.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 13 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in India. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Deepti Vibha (+91-9868398263, deeptivibha@aiims.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Western Aphasia Battery Score (time frame: 8 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2026.